Related Articles by Review for PMID: 19388167

Year	Number of Results
1999	2
2001	1
2008	5
2016	2
2018	1
2019	3
2020	1
2022	1
2023	1
2024	1

1

Species-specificity of Neisseria gonorrhoeae infection: do human complement regulators contribute?

Ngampasutadol J, Tran C, Gulati S, Blom AM, Jerse EA, Ram S, Rice PA. Ngampasutadol J, et al. Vaccine. 2008 Dec 30;26 Suppl 8:I62-6. doi: 10.1016/j.vaccine.2008.11.051. Vaccine. 2008. PMID: 19388167 Review.

2

Contribution of interactions between complement inhibitor C4b-binding protein and pathogens to their ability to establish infection with particular emphasis on Neisseria gonorrhoeae.

Blom AM, Ram S. Blom AM, et al. Vaccine. 2008 Dec 30;26 Suppl 8:I49-55. doi: 10.1016/j.vaccine.2008.11.049. Vaccine. 2008. PMID: 19388165 Review.

3

C4bp binding to porin mediates stable serum resistance of Neisseria gonorrhoeae.

Ram S, Cullinane M, Blom AM, Gulati S, McQuillen DP, Boden R, Monks BG, O'Connell C, Elkins C, Pangburn MK, Dahlbäck B, Rice PA. Ram S, et al. Int Immunopharmacol. 2001 Mar;1(3):423-32. doi: 10.1016/s1567-5769(00)00037-0. Int Immunopharmacol. 2001. PMID: 11367527 Review.

4

Factor H and neisserial pathogenesis.

Welsch JA, Ram S. Welsch JA, et al. Vaccine. 2008 Dec 30;26 Suppl 8(Suppl 8):I40-5. doi: 10.1016/j.vaccine.2008.11.060. Vaccine. 2008. PMID: 19388163 Free PMC article. Review.

5

The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis.

Ram S, Mackinnon FG, Gulati S, McQuillen DP, Vogel U, Frosch M, Elkins C, Guttormsen HK, Wetzler LM, Oppermann M, Pangburn MK, Rice PA. Ram S, et al. Mol Immunol. 1999 Sep-Oct;36(13-14):915-28. doi: 10.1016/s0161-5890(99)00114-5. Mol Immunol. 1999. PMID: 10698346 Review.

6

Complement interactions with the pathogenic Neisseriae: clinical features, deficiency states, and evasion mechanisms.

Lewis LA, Ram S. Lewis LA, et al. FEBS Lett. 2020 Aug;594(16):2670-2694. doi: 10.1002/1873-3468.13760. Epub 2020 Mar 3. FEBS Lett. 2020. PMID: 32058583 Free article. Review.

7

Progress Toward a Gonococcal Vaccine: The Way Forward.

Russell MW, Jerse AE, Gray-Owen SD. Russell MW, et al. Front Immunol. 2019 Oct 15;10:2417. doi: 10.3389/fimmu.2019.02417. eCollection 2019. Front Immunol. 2019. PMID: 31681305 Free PMC article. Review.

8

[Immunological mechanisms of Neisseria gonorrhoeae infection: An update].

Li XC, Su XH. Li XC, et al. Zhonghua Nan Ke Xue. 2018 May;24(5):452-456. Zhonghua Nan Ke Xue. 2018. PMID: 30171763 Review. Chinese.

9

Utilizing complement evasion strategies to design complement-based antibacterial immunotherapeutics: Lessons from the pathogenic Neisseriae.

Ram S, Shaughnessy J, DeOliveira RB, Lewis LA, Gulati S, Rice PA. Ram S, et al. Immunobiology. 2016 Oct;221(10):1110-23. doi: 10.1016/j.imbio.2016.05.016. Epub 2016 Jun 1. Immunobiology. 2016. PMID: 27297292 Free PMC article. Review.

10

Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.

Gulati S, Shaughnessy J, Ram S, Rice PA. Gulati S, et al. Front Immunol. 2019 Feb 27;10:321. doi: 10.3389/fimmu.2019.00321. eCollection 2019. Front Immunol. 2019. PMID: 30873172 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year